Roche Holding AG is in talks to buy the rest of Genentech Inc it does not already own for about $95 per share, a source familiar with the situation said on Monday.

The new price was enough to get both sides to the table, said the source, who was not authorized to speak to the press.

Roche and Genentech declined to comment.

(Reporting by Jessica Hall; editing by Jeffrey Benkoe)

(For more M&A news and our DealZone blog, go to